Hi NEU followers,
just came across this interesting article. It is describing the painpoints to develop any drugs for Huntington`s Disease. Reading through this, I feel like it was a wise decision not to pick this indication for development. It seems this space is tough to address. Here is the link to the article, happy reading.
https://www.biospace.com/article/huntington-s-is-biopharma-spinning-its-wheels-/?keywords=Huntington
Science & Company decision making
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.24 |
Change
-0.080(0.52%) |
Mkt cap ! $1.954B | |||
| Open | High | Low | Value | Volume |
| $15.10 | $15.39 | $15.04 | $3.113M | 204.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 154 | $15.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.26 | 130 | 4 |
View Market Depth
| Last trade - 14.02pm 21/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |